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Forward Transport: 14-3-3 Binding Overcomes
Retention in Endoplasmic Reticulum
by Dibasic Signals
gen signaling, and neuronal plasticity (Fu et al., 2000;
Tzivion and Avruch, 2002). These 30 kDa, soluble, cy-
toplasmic proteins exert their recognized influences
by binding to the consensus motifs -RSXSPXP- and
-RXXXSPXP- (hyphen indicates linkage to other resi-
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dues) present on kinases, phosphatases, and trans-Boyer Center for Molecular Medicine
membrane receptors after a serine in the motif is phos-New Haven, Connecticut 06536
phorylated (SP) (Toker et al., 1990; Freed et al., 1994;
Pallas et al., 1994; Muslin et al., 1996; Campbell et al.,
1997; Craparo et al., 1997; Thorson et al., 1998; ZhouSummary
et al., 1999). A role for 14-3-3 in intracellular protein
trafficking has been inferred from its capacity to rescueProteins with dibasic retention motifs are subject to
yeast cells with clathrin heavy chain mutations (Gelperinretrograde transport to endoplasmic reticulum (ER) by
et al., 1995), enhance expression of neuronal acetylcho-COPI-coated vesicles. As forward transport requires
line receptors (Jeanclos et al., 2001), and alter levelsescape from ER retention, general release mecha-
of immune complexes on cells defective for clathrin-nisms have been expected. Here, KCNK3 potassium
mediated endocytosis (Kuwana et al., 1998).channels are shown to bear two cytoplasmic traffick-
KCNK channels pass background potassium currentsing motifs: an N-terminal dibasic site that binds -COP
that regulate the behavior of nerves and muscles (Le-to hold channels in ER and a C-terminal “release” site
sage and Lazdunski, 2000; Goldstein et al., 2001). Sub-that binds the ubiquitous intracellular regulator 14-
ject to dynamic regulation in current magnitude, KCNK33-3 on a nonclassical motif in a phosphorylation-
channels are homodimeric complexes (Lopes et al.,dependent fashion to suppress -COP binding and
2001) implicated in responses of the heart and centralallow forward transport. The strategy appears to be
nervous system to hormones, neurotransmitters, acido-common. The major histocompatibility antigen class
sis, hypoxia, and local and volatile anesthetics. In thisII-associated invariant chain Iip35 exhibits dibasic re-
study, surface expression of KCNK3 is found to be con-tention, carries a release motif, and shows mutually
trolled by interplay of two sites: a dibasic site on the Nexclusive binding of -COP and 14-3-3 on adjacent
terminus that binds -COP to retain channels in ER andN-terminal sites. Other retained proteins are demon-
a C-terminal release site that binds 14-3-3 to a nonclas-strated to carry functional 14-3-3 release motifs.
sical motif (-RRSSPV), allowing forward transport. Thus,
mutations that abolish 14-3-3 binding suppress traf-Introduction
ficking to the plasma membrane while surface expres-
sion is restored by ablation of the dibasic site or restitu-Newly synthesized proteins destined for membrane ex-
tion of 14-3-3 binding on the channel C terminus, forpression fold within the endoplasmic reticulum (ER) and
example, by creation of a classical 14-3-3 site as foundtravel forward through the cis-golgi complex (Ellgaard
in Raf1 kinase (-RSASPEP). A mechanism is suggestedet al., 1999; Mellman and Warren, 2000). Misfolded or
by demonstration that (despite separation of retentionresident proteins that escape the ER are retrieved into
and release motifs in the KCNK3 primary sequence) theCOPI-coated vesicles for retrograde transport (Letour-
channels bind -COP or 14-3-3 in mutually exclusiveneur et al., 1994; Gaynor and Emr, 1997). COPI vesicles
fashion.
operate with notable specificity, recovering proteins
The presence of 14-3-3 binding motifs in other pro-
through interaction with cytoplasmic dibasic “retrieval”
teins subject to ER retention via dibasic signals suggests
motifs (Nilsson et al., 1989; Teasdale and Jackson, 1996; that operation of release sites may be common. Func-
Zerangue et al., 2001). How COPI vesicular machinery tional -COP and 14-3-3 release motifs are demon-
(a complex of at least seven proteins) differentiates strated in three other membrane proteins. KCNK9 chan-
cargo for retention or forward transport is unknown. A nels are shown to bear an N-terminal retention site
masking strategy has been proposed in cases where identical to that in KCNK3 and a similar C-terminal re-
expression is limited to fully assembled heteromeric lease site (-RRKSPV). Nicotinic acetylcholine 4 subunits
complexes: the retention signal on one subunit hid- are shown to carry a dibasic motif analogous to a site
den through assembly with its nonidentical partner(s) that retains skeletal muscle  subunits in ER (Keller et
(Klausner, 1990; Zerangue et al., 1999; Standley et al., al., 2001) and a variant release site (-RSLSPV-), both on
2000; Zarei et al., 2001). Here, the cytoplasmic protein a large cytoplasmic loop previously demonstrated to
14-3-3 is shown to act in a phosphorylation-dependent influence surface expression and to bind 14-3-3
fashion to inhibit association of COPI proteins with diba- (Jeanclos et al., 2001).
sic sites and allow forward transport. The cytoplasmic N terminus of the Iip35 major histo-
The seven known isoforms of 14-3-3 have been as- compatibility antigen class II-associated invariant chain
cribed roles in biological activities as diverse as apo- has a dibasic motif that maintains the subunit in ER
ptotic cell death, cell cycle control, cell adhesion, mito- (Schutze et al., 1994). Phosphorylation of the subunit
has been shown to regulate forward trafficking of class
II complexes (Anderson et al., 1999), alter release from1Correspondence: steve.goldstein@yale.edu
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Figure 1. The KCNK3 C Terminus Is Phos-
phorylated and Binds 14-3-3 in Rat Brain
(A) KCNK3 topology; N- and C-terminal resi-
dues shown.
(B) Homogenized and detergent-solubilized
rat brain was incubated with immobilized
RRSSV peptides, RRSSPV peptides, or pep-
tide-free beads (as indicated). Interacting
proteins were eluted, separated by SDS-
PAGE, and stained with Coomassie blue. Two
major products bound to the phosphorylated
peptide (RRSSPV). Markers are kDa.
(C) MALDI analysis of major bound products
from gel in (B) with key peaks labeled by size.
Analysis using Sequest algorithms (NCBI)
identify the proteins as 14-3-3 and 14-3-3
with a probability close to or equal to 1.
(D) Isolation of 14-3-3 from rat brain lysate
by binding to phosphorylated KCNK3 peptide
(RRSSPV) but not nonphosphorylated (RRSSV)
peptide. Interacting proteins were eluted and
separated by SDS-PAGE and visualized by
Western blot analysis using a monoclonal an-
tibody to 14-3-3 and ECL. Rat heart and
skeletal muscle yield 14-3-3 by the same
strategy (not shown).
(E) KCNK3 channels were copurified from rat
brain when a monoclonal antibody was used
to immunoprecipitate (IP) 14-3-3 (top).
KCNK3 channels purified in this manner are
visualized by antibodies to phosphoserine
(bottom). Proteins separated by SDS-PAGE
and visualized by Western blot analysis using
a polyclonal anti-KCNK3 or anti-phosphoser-
ine (SP) antibody, as indicated, and ECL. Con-
trol indicates immunoprecipitation with non-
immune mouse IgG.
ER, and lead to 14-3-3 binding (Kuwana et al., 1998). dependent binding of 14-3-3 to the cargo, termination of
COPI protein association, and release from ER retention.Inspection reveals that Iip35 carries a retention site
(MHRRRSRSC-) adjacent to a variant release site
(MHRRRSRSPC-). Here, we find that like KCNK3, Iip35 Results
binds either -COP or 14-3-3 in mutually exclusive
fashion. When the terminus is not phosphorylated, KCNK3 Peptide Identifies 14-3-3
-COP binds (even in the presence of 14-3-3); upon KCNK3 subunits are predicted to have cytoplasmic N
phosphorylation, 14-3-3 binds and -COP association and C termini, two pore loops, and four transmembrane
is suppressed. segments (Figure 1A; Goldstein et al., 2001). The five
A general mechanism for regulated anterograde traf- carboxy-terminal residues of KCNK3 (residues 390–
ficking is thus suggested. That 14-3-3 binds to KCNK3 394, -RRSSV) contain a consensus site for phosphoryla-
to inhibit association of -COP leading to release of tion and suggest a potential PDZ-type binding motif. To
homodimeric channels from ER retention, and that 14- probe the terminus for protein-protein interactions, a
3-3 binds to Iip35 invariant chains to suppress -COP human heart cDNA library was screened by a yeast two-
binding under conditions that stimulate forward traffick- hybrid method using Gal4-based signaling and the last
ing of heteromeric class II complexes (Anderson et al., 16 residues of human KCNK3 as bait. Screening pro-
1999) indicates that forward transport of proteins with duced two independent isolates of the gene for 14-3-3
(GenBank accession number P31946) and the upstreamdibasic retention motifs is favored by phosphorylation-
Forward Transport: 14-3-3 Overcomes ER Retention
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Table 1. Peptides Used in This Work
Description Name in Text Full Product
KCNK3 C terminus -RRSSV -CHSLSTFRGLMKRRSSV
KCNK3 C terminus  P -RRSSPV -CHSLSTFRGLMKRRSSPV
KCNK3 with Raf1 site -RSASEP- -CSTFRGLMKRSASEP
KCNK3 with Raf1 site  P -RSASpEP -CSTFRGLMKRSASPEP
KCNK3V C terminus -RSS -CHSLSTFRGLMKRRSS
KCNK3V C terminus  P -RSSp -CHSLSTFRGLMKRRSSP
KCNK3 N terminus -KR- MKRQNVAC-
NQ-KCNK3 N terminus -NQ- MNQQNVAC-
KCNK9 C terminus -RRKSV -CFTDHQRLMKRRKSV
KCNK9 C terminus  P -RRKSpV -CFTDHQRLMKRRKSPV
Human 4 loop -RSLSV- -CAPGLAKARSLSVQHMSSPG
Human 4 loop  P -RSLSpV- -CAPGLAKARSLSPVQHMSSPG
Human 4 loop -RR- MPTWVRRVFLDIVPRC-
Iip35 N terminus MHRRRSRSC- MHRRRSRSCREDQKC-
Iip35 N terminus  P MHRRRSRSpC- MHRRRSRSPCREDQKC-
Iip35 N terminus no S MHRRRSREC- MHRRRSRECREDQKC-
HA peptide HA peptide YPYDVPDYA
FLAG peptide FLAG peptide DYKDDDDK
Peptides were synthesized as described in Experimental Procedures; a dash (-) indicates position of linkage to beads or other residues in
the protein.
untranslated region of a known protein. This was unex- (P) two positions downstream and in its location at the
protein C terminus (Muslin et al., 1996; Yaffe et al., 1997;pected, as the bait did not contain either common motif
for 14-3-3 binding, -RSXSPXP- or -RXXXSPXP- (Tzivion Rittinger et al., 1999). To evaluate these unique attri-
butes, isolation of native 14-3-3 from rat brain wasand Avruch, 2002).
studied with various immobilized peptides. First, the
KCNK3 residues -RRSSPV were replaced with a classicalKCNK3 Binds 14-3-3 in Rat Brain
binding motif (-RSASPEP-) that is present in the middleInteraction of 14-3-3 and the KCNK3 bait was con-
of the canonical 14-3-3 binding protein Raf1 kinase; thisfirmed at the protein level with two KCNK3 peptides
showed that, like the atypical site in KCNK3, a classicalidentical to the terminal 16 amino acids of the channel
site could mediate phosphorylation-dependent binding(Table 1). As 14-3-3 binding to classical motifs requires
of 14-3-3 when located at a C terminus (Figure 2A).phosphorylation, the first peptide carried serine at the
Next, the KCNK3 site was shown to require its terminalpenultimate position (-RRSSV), the second a phospho-
valine since 14-3-3 did not bind to peptides terminat-serine (-RRSSPV). The peptides were immobilized on
ing -RRSS or -RRSSP (Figure 2A).beads and incubated with homogenized, detergent-sol-
ubilized rat brain. After washing to remove weakly asso-
ciated proteins, bound products were eluted with 1% KCNK3V Channels Do Not Function
sodium dodecylsulfate (SDS) and separated by poly- To assess the effect of 14-3-3 on KCNK3, function
acrylamide electrophoresis (SDS-PAGE). Coomassie of channels expressed in Xenopus laevis oocytes was
blue staining revealed that two major products bound studied by two-electrode voltage clamp. Wild-type
only to the phosphorylated peptide (Figure 1B). These KCNK3 channels were first compared to mutants that
products were identified by MALDI-MS analyses to be terminated like the peptides that bound 14-3-3 via the
14-3-3 and 14-3-3 (Figure 1C). classical motif found in Raf1 (KCNK3-RSASPEP). The
As expected from studies of classical motifs (Muslin two channels produced currents that were indistinguish-
et al., 1996), antibody staining demonstrated that native able (Figure 2B). Thus, cells expressing wild-type
14-3-3 from rat brain or heart or skeletal muscle bound KCNK3 or KCNK3-RSASPEP channels showed currents
only to the phosphorylated KCNK3 peptide (Figure 1D). not seen in control cells and like those observed pre-
Indicating association of native 14-3-3 and KCNK3 viously (Lopes et al., 2000, 2001). Currents produced by
channels in vivo, the channels were copurified when a voltage steps showed a major component that appeared
monoclonal antibody was used to immunoprecipitate to activate and deactivate instantaneously and a smaller
14-3-3 from rat brain (Figure 1E, top). The native KCNK3 time-dependent component (Figure 2B). The channels
subunits purified with 14-3-3 were phosphorylated on also showed the same selectivity for potassium as
serine (Figure 1E, bottom); studies of cloned human judged by reversal potential (shifting 60mV  1mV and
KCNK3 channels (below) show that serine phosphoryla- 60mV  2mV with a change in bath potassium from 5
tion and 14-3-3 binding occur on the C-terminal motif to 100 mM for mutant and wild-type, respectively, n 
of the intact channel. 6–8 cells). Moreover, in both cases acidification of the
external medium from pH 7.4 to 6.5 produced nearly com-
plete blockade (Figure 2C). In contrast, mutant KCNK3The Final Valine Is Required to Bind 14-3-3
The 14-3-3 site in KCNK3 is like classical sites in requir- subunits that terminated like the peptide that could not
bind 14-3-3 due to deletion of the final valine residueing a phosphoserine but atypical both for lacking proline
Cell
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Figure 2. KCNK3V Does Not Bind 14-3-3 or Pass Current
Figure 3. KCNK3V Does Not Reach the Surface, whereas NQ-(A) Isolation of 14-3-3 from rat brain was achieved by binding to
KCNK3V Doesthe phosphorylated KCNK3 (RRSSPV) and Raf1 peptide (RSASPEP)
(A) Surface expression of HA-tagged KCNK3, KCNK3V, and NQ-but not phosphorylated peptide without the final valine (RRSSP) or
KCNK3V on single oocytes quantified by antibody labeling andthe nonphosphorylated peptides. Interacting proteins were eluted,
luminometry. Plot is relative light units (RLU) for groups of 6–10separated, and visualized by Western blot analysis using a mono-
cells less nonspecific background fluorescence (mean  SEM). HA-clonal antibody to 14-3-3 and ECL.
tagged, wild-type KCNK3 subunits yielded a strong surface signal,(B) Wild-type and KCNK3-RSASPEP channels show similar current
while HA-tagged KCNK3V and untagged wild-type KCNK3 chan-levels but KCNK3V channels passed no current. Raw two-elec-
nels showed the same null fluorescence of uninjected oocytes. NQ-trode voltage clamp recordings of oocytes expressing KCNK3 with
KCNK3V showed surface expression not significantly differentvarious C termini as indicated. KCNK3 channels, KCNK3 channels
from HA-tagged wild-type KCNK3.with a Raf1-like C terminus (KCNK3-RSASPEP), and KCNK3V
(B) SDS-PAGE and Western blot analysis showed similar levels ofchannels.
HA-tagged KCNK3, KCNK3V, and NQ-KCNK3V in total cell ly-(C) Mean currents ( SEM) evoked in oocytes by step depolarization
sates.to 30mV for groups of 6–10 cells in external bath solutions of pH
(C) Raw currents passed by single cells expressing indicated KCNK37.4 and 6.5 as labeled.
channels.
(D) Mean ( SEM) current from groups of 6–10 cells at pH 7.4 and 6.5.
(KCNK3V) produced no currents in the oocytes (Figures
2B and 2C). Furthermore, a variant KCNK3 C-terminal pep-
tide with diminished but not absent 14-3-3 binding channels on the surface was not due to failure to synthe-
(-RRSPSV) was associated with mutant KCNK3 chan- size the protein; study of cells expressing HA-tagged
nels that showed depressed but not ablated current wild-type and KCNK3V channels by homogenization,
(KCNK3-RRSAV, KCNK3-RQSSV, and KCNK3-QRSSV, SDS-PAGE, and Western blot analysis showed that simi-
not shown). These findings suggested that 14-3-3 was
lar levels of the two proteins were produced (Figure 3B).
required either to allow channels to reach the surface
Since the biophysical attributes of HA-tagged KCNK3or to operate once inserted into the plasma membrane.
channels were the same as their untagged counterparts,
it seemed unlikely the tag further interfered with functionKCNK3V Channels Do Not Reach the Surface
of KCNK3V channels (Figures 3C and 3D).A binding assay demonstrated that KCNK3V subunits
fail to reach the plasma membrane. A hemagglutinin
An N-Terminal Dibasic Motif Holds KCNK3V(HA) epitope tag was introduced into wild-type KCNK3
Channels inside the Cellsand KCNK3V after the second pore domain, a site
KCNK3 subunits carry a potential ER retention motif,predicted to be exposed to the external milieu. Each
KR, at positions 2–3. To examine whether the motif hadoocyte was first studied by two-electrode voltage
a role in failure of KCNK3V subunits to reach the sur-clamp, and then channel protein on the surface of intact
face, the residues were altered by mutation to NQ (Figurecells was quantified using anti-HA antibody, a second-
3A). The change restored function to KCNK3V chan-ary antibody conjugated with horseradish peroxidase,
nels: NQ-KCNK3V subunits bearing an HA-tag showedand luminometery, a method developed by others (Zer-
strong surface signals (Figure 3A), and although currentsangue et al., 1999). Whereas HA-tagged, wild-type
were smaller in magnitude, NQ-KCNK3V channelsKCNK3 subunits yielded a strong surface signal, HA-
were like untagged or HA-tagged wild-type KCNK3tagged KCNK3V and untagged wild-type KCNK3 chan-
channels in their response to voltage steps (Figure 3C),nels showed the same null level of fluorescence as unin-
jected oocytes (Figure 3A). Failure to detect KCNK3V selectivity for potassium (shifting 58mV  2mV with a
Forward Transport: 14-3-3 Overcomes ER Retention
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Figure 4. A Dibasic Motif Holds KCNK3 Channels in Endoplasmic Reticulum
COS-7 cells expressing HA and FLAG-tagged constructs of wild-type KCNK3, KCNK3V, or NQ-KCNK3V were labeled with anti-HA antibodies
to stain the surface or anti-FLAG antibodies to visualize intracellular KCNK3V after permeabilization.
(A) Wild-type KCNK3 channels are observed at the plasma membrane.
(B) KCNK3V channels are not visualized on the plasma membrane (top), whereas transferrin receptors are visualized on the plasma membrane
(middle). Permeabilization with detergent reveals KCNK3V channels accumulate in perinuclear areas (bottom).
(C) NQ-KCNK3V channels escape ER retention to reach the plasma membrane.
change in bath potassium from 5 to 100 mM, n  6 tomer retrieval/retention mechanism (Ellgaard et al.,
1999; Mellman and Warren, 2000), HA-tagged KCNK3cells), and inhibition by external acidification (Figure 3D).
This supported the conclusions that on its own the V channels were expressed in COS-7 cells and associated
native proteins evaluated by immunoprecipitation. Fig-mutation altered surface expression but not capacity to
pass current and that 14-3-3 was not required for normal ure 5A shows that affinity purification with antibodies
to HA isolated wild-type KCNK3 (top left) in associationfunction of the channel once it had achieved surface
expression. with -COP (top right); conversely, KCNK3 channels al-
tered from KR to NQ in the N-terminal dibasic motifKCNK3 channels expressed in mammalian tissue cul-
ture cells (COS-7) behaved like those studied in oocytes. were purified like wild-type (lower left) but were not
associated with -COP (lower right).Thus, wild-type channels were transported to the
plasma membrane (Figure 4A); KCNK3V channels did Immunoprecipitation of HA-tagged KCNK3 channels
from COS-7 cells also led to isolation of associatednot reach the surface (Figure 4B, top) while surface
transferrin receptor was readily apparent (Figure 4B, native 14-3-3 (Figure 5B, top left). Like KCNK3 channels
in rat brain (Figure 1E), the cloned channels associatedmiddle); and finally, N-terminal mutation to form NQ-
KCNK3V channels restored transport to the surface with 14-3-3 carried phosphate on serine (Figure 5B, top
right). Further evidence that phosphoryation and 14-3-3(Figure 4C). Cell permeabilization showed KCNK3V
channels to be held in perinuclear areas as expected binding occurred at the KCNK3 C terminus was offered
by mutation of the clone to remove the only serine phos-(Figure 4B, bottom). Immunostain and Western blot anal-
yses revealed native 14-3-3 to be prominent in COS-7 phorylation consensus site external to the C terminus
(S358A KCNK3), as this did not interfere with 14-3-3cells (with a diffuse cytoplasmic pattern), suggesting
why heterologous expression of recombinant 14-3-3 binding (Figure 5B, bottom left) or phosphoserine stain-
ing (Figure 5B, bottom right).did not change the trafficking patterns of the three
KCNK3 variants (not shown). The HA immunoprecipitates were shown to contain
two separable populations of KCNK3 subunits, one as-
sociated with -COP, the other with 14-3-3, as followsKCNK3 Binds Either -COP or 14-3-3
To confirm that ER retention of KCNK3 channels was (Figure 5C): a second immunoprecipitation step (IP2) to
reisolate -COP led to repurification of KCNK3 (left) andmediated via the N-terminal dibasic signal and the coa-
Cell
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Figure 5. KCNK3 Binds -COP or 14-3-3 in Mutually Exclusive Fashion
KCNK3 channels (HA-tagged) were expressed in COS-7 cells and studied by detergent extraction, immunoprecipitation, separation by SDS-
PAGE, and visualization by Western blot analysis using antibodies as indicated with ECL.
(A) KCNK3 channels purified by immunoprecipitation (IP) with anti-HA antibodies and visualized with antibody to HA (top left) led to copurification
of native COP (top right). Conversely, NQ-KCNK3 channels mutated from KR to NQ in the dibasic motif were isolated (bottom left) in the
absence of native COP (bottom right). Control indicates immunoprecipitations with nonimmune mouse IgG.
(B) KCNK3 channels isolated as in (A) copurified native 14-3-3 (top left) that was phosphorylated on serine (top right). S358A KCNK3 channels
mutated in the only internal consensus site for serine phosphorylation showed 14-3-3 binding (bottom left) and serine phosphorylation (bottom
right) like wild-type. Control indicates immunoprecipitation with nonimmune mouse IgG.
(C) KCNK3 immunoprecipitates as in (A) were eluted from the beads with HA peptide and subjected to a second round of affinity purification
(IP2) with antibody to COP or 14-3-3 and visualized with antibody to HA (left), COP (middle), and 14-3-3 (right); this revealed two
populations of KCNK3 subunits: one with COP, another with 14-3-3; failure to detect COP and 14-3-3 indicate levels are at least 90%
and 95% less than bound to an equal amount of KCNK3 in IP1 (Experimental Procedures).
-COP (middle) but not 14-3-3 (right); conversely, IP2 54% identical to KCNK3 (the first nine residues of the
to reisolate 14-3-3 yielded KCNK3 (left) and 14-3-3 two channels containing the KCNK3 dibasic retention
(right) but not -COP (middle). Failure to detect 14-3-3 motif are exactly alike) and predicted to have the same
associated with KCNK3 in the -COP IP2 indicated its membrane topology (Kim et al., 2000). As expected,
depletion to less than 5% of levels carried by unfraction- peptides matching the wild-type KCNK9/KCNK3 N ter-
ated KCNK3 in IP1 (Experimental Procedures); depletion minus were found to bind -COP from rat brain, whereas
of -COP in the 14-3-3 IP2 was similarly demonstrated peptides that disrupted the motif (and allowed NQ-
to exceed 90%. These findings supported the conclu- KCNK3V channels to escape ER retention) did not (Fig-
sion that KCNK3 channels were held in ER via the COPI ure 6A, left). The C-terminal residues in KCNK9 subunits
retention pathway and that phosphorylation-dependent (-RRKSV) are similar to those in KCNK3 (-RRSSV), and
binding of 14-3-3 suppressed COPI association to facili- the peptide analogous to the KCNK9 terminus was dem-
tate forward transport. onstrated, as anticipated, to bind 14-3-3 from rat brain
when the penultimate serine was phosphorylated (Fig-
ure 6A, right).Release Motifs in KCNK9, 4, and Iip35
Neuronal nicotinic acetylcholine receptors (nAChR)To explore the idea that proteins other than KCNK3
are ligand-gated, nonselective cation channels and at-might employ a 14-3-3 release strategy, we studied pep-
tain surface expression after homo- or heteropentam-tides based on three plasma membrane subunits sub-
eric assembly (McGehee, 1999). Support for the opera-ject to ER retention by the COPI-dibasic signal pathway
tion of -COP retention and 14-3-3 release motifs inwhere prior studies had implicated phosphorylation
and/or 14-3-3 in forward transport. KCNK9 channels are neuronal 4 subunits was obtained as follows. Skeletal
Forward Transport: 14-3-3 Overcomes ER Retention
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Figure 6. Retention and Release Motifs on KCNK9, 4, and Iip35: Phosphorylated Iip35 Binds 14-3-3, Leading to Blockade of -COP
Association
Isolation of COP and/or 14-3-3 from rat brain lysate using peptide-coupled beads. Interacting proteins were eluted, separated by SDS-
PAGE, and visualized by Western blot analysis using monoclonal antibodies as indicated and ECL.
(A) The peptide analogous to the wild-type N terminus of KCNK9 (and KCNK3) binds -COP from rat brain, while peptides with the NQ mutation
do not (left). The C-terminal residues in KCNK9 subunits (RRKSPV) bind 14-3-3 from rat brain if the penultimate serine is phosphorylated
(right). Drawing suggests the membrane topology of a KCNK9 subunit.
(B) A peptide analogous to a portion of the human neuronal 4 acetylcholine receptor large cytoplasmic loop binds -COP from rat brain
(-RR-, positions 347–348), left. A peptide identical to another portion of the loop binds native 14-3-3when phosphorylated (-RSLSPV-, positions
464–468; GenBank accession U62433), right. Drawing suggests the membrane topology of an 4 subunit.
(C) Isolation of native -COP from rat brain in the presence of native 14-3-3 (top): nonphosphorylated Iip35 (and SP to E) peptides bind -COP
well but the peptide analogous to phosphorylated Iip35 (MHRRRSRSPC) does not. Binding of native 14-3-3 is seen when the Iip35 sequence
is phosphorylated (MHRRRSRSPC) but not nonphosphorylated or the SP to E variant (middle). Prebinding of recombinant 14-3-3 ablates
-COP binding to the phosphorylated Iip35 sequence (bottom). Drawing suggests the membrane topology of an Iip35 subunit.
muscle subunits are confined to ER by a dibasic signal, phosphorylation regulates forward trafficking of class II
complexes (Anderson et al., 1999) in association withRK (positions 313–314) (Keller et al., 2001) and released
after assembly of , , , and 	 subunits (this appears 14-3-3 binding (Kuwana et al., 1998). Kuwana and co-
workers (Kuwana et al., 1998) further showed that it isto mask the  subunit retention signal). We found a
similar motif in the large cytoplasmic loop of neuronal serine 8 of Iip35 that bears phosphate in vivo and that
mutation of the site to alanine suppressed 14-3-34 subunits (RR, positions 347–348) that bound -COP
from rat brain (Figure 6B, left). Jeanclos and colleagues binding.
(Jeanclos et al., 2001) identified a motif in the same loop
of 4 subunits (-RSLSVQ-, positions 438–443) that binds 14-3-3 Blocks -COP Binding to Iip35
The Iip35 N terminus carries a basic retention motif,14-3-3
, leading to an increase of homomeric 4 com-
plexes on the surface (a smaller effect was seen on MHRRRSRSC-, followed by a suspected 14-3-3 release
site. Using rat brain as a source of native -COP andheteromeric 42 complexes). Consistent with their po-
tential role as a KCNK3-like release site, these 4 resi- 14-3-3, the nonphosphorylated terminus was found to
bind a significant level of -COP in the presence of 14-dues were also found to bind 14-3-3 from rat brain
when phosphorylated, -RSLSPVQ- (Figure 6B, right). 3-3 but not when the terminus was phosphorylated
(MHRRRSRSPC-) (Figure 6C, top). Conversely, 14-3-3Ii chains associate with newly synthesized class II
molecules in ER to control their forward trafficking to bound only to the phosphorylated form of the N terminus
(Figure 6C, middle). We suspected that poor bindingantigen-processing compartments and prevent un-
wanted interaction of peptides with the class II binding of -COP to the phosphorylated terminus was due to
blocking of its binding site by 14-3-3. To test this idea,groove during passage through the secretory pathway
(Roche, 1990; Teyton, 1990; Cresswell, 1994). The oper- -COP binding was studied again using termini pre-
treated with recombinant human 14-3-3 synthesizedation of COPI retention and 14-3-3 release sites was
strongly suggested by the observations that a dibasic and purified from E. coli. As expected, exposure to 14-
3-3 did not alter -COP binding to the nonphos-motif retains Iip35 in ER (Schutze et al., 1994) and that
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Figure 7. Iip35 In Vivo Binds -COP or 14-3-3 in Mutually Exclusive Fashion
COS-7 cells overexpressing Iip35 (FLAG-tagged) were studied by detergent extraction, immunoprecipitation, SDS-PAGE, and Western blot
analysis with ECL.
(A) Iip35 was purified by immunoprecipitation with FLAG antibodies and visualized by antibody to Iip35 (top left); anti-phosphoserine antibodies
showed Iip35 to be phosphorylated on serine (bottom left) as expected (Kuwana et al., 1998). Isolation of Iip35 led to copurification of native
COP (middle) and native 14-3-3 (right). Control immunoprecipitation with nonimmune IgG.
(B) When the Iip35 immunoprecipitate was eluted from the beads with FLAG peptide and subjected to a second round of affinity purification
with antibody to COP (left column) or 14-3-3 (right column) and visualized by antibody to Iip35 (left), COP (middle), and 14-3-3 (right),
two populations of Iip35 subunits were identified: one with COP, another with 14-3-3.
phorylated terminus but ablated binding to the phos- mutated (Figure 5A, bottom), suggesting no other-COP
binding site is present. Similarly, N-terminal Iip35 andphorylated form (Figure 6C, bottom). Supporting the
conclusion that phosphorylation per se did not inhibit KCNK3 peptides bind -COP (Figures 6A and 6C) while
C-terminal KCNK3 peptides do not (not shown). Finally,association of -COP with its site, mutation of the SP site
to a negatively charged glutamic acid (MHRRRSREC-) it is the wild-type N terminus that retains KCNK3V
channels inside cells (Figures 2, 3, and 4), as its mutationdid not interfere with -COP binding (Figure 6C, top) nor
allow 14-3-3 binding (Figure 6C, middle). The retention to form NQ-KCNK3V channels allows release to the
surface (Figures 3 and 4).and release sites thus operate in exclusive fashion such
that 14-3-3 binding precludes -COP association.
Discussion
Iip35 Binds Only -COP or 14-3-3 In Vivo
The behavior of Iip35 in vivo supported operation of Regulated surface expression of plasma membrane re-
ceptors is key to normal cellular physiology (Ellgaarda mechanism for forward transport like that found for
KCNK3: ER retention via the COPI-dibasic pathway and et al., 1999; Mellman and Warren, 2000). Membrane
trafficking proceeds under tight control to establishphosphorylation-dependent binding of 14-3-3 leading
to inhibition of COPI binding and release from ER due steady-state expression levels, respond to acute stimuli,
and monitor the quality of secreted multimeric products.to mutually exclusive binding. Thus, immunoprecipita-
tion of Iip35 (bearing a C-terminal FLAG tag) from COS-7 One cellular strategy is to maintain proteins in ER through
retention and recovery in COPI-coated vesicles viacells with FLAG antibodies yielded Iip35 that was phos-
phorylated on serine (Figure 7A, left). As with KCNK3, the “dibasic” recognition of sites of one, two, or three se-
quential arginine or lysine residues (Nilsson et al., 1989;primary Iip35 immunoprecipitate contained both native
COP and 14-3-3 (Figure 7A, middle and right), and Teasdale and Jackson, 1996; Zerangue et al., 2001).
While masking of retention signals appears to allowthe two mediators were found to reside in separate pop-
ulations of Iip35 complexes (Figure 7B): subjecting the some mixed complexes to escape the ER (Zerangue et
al., 1999; Standley et al., 2000; Zarei et al., 2001), generalimmunoprecipitate to a second affinity purification step
(IP2) to reisolate 14-3-3 yielded Iip35 and 14-3-3 (left methods to overcome suppression have been unknown.
In this study, we show that surface expression of KCNK3and right columns) but not -COP (middle column), while
reisolation of -COP rendered Iip35 and -COP (left and channels is achieved by phosphorylation-dependent
binding of 14-3-3 and release from COPI-mediated ERmiddle columns) but not 14-3-3 (right column).
Although KCNK3 has multiple basic residues in its retention. The mechanistic basis for forward transport
of KCNK3 appears to be mutually exclusive binding ofC-terminal 14-3-3 binding site (-KRRSSV), they do not
appear to play a direct role in ER retention as do those -COP and 14-3-3. Functional -COP retention and
14-3-3 release motifs are demonstrated in three otherat the Iip35 N terminus. Thus, wild-type KCNK3 channels
bind -COP (Figure 5A, top) unless the N terminus is proteins (KCNK9 channels, 4 nicotinic acetylcholine
Forward Transport: 14-3-3 Overcomes ER Retention
585
receptors, and Iip35). Retention and release sites on ing, whereas 42 receptors (thought to be the promi-
nent in vivo species) can employ 2 masking and arethe immune system protein are adjacent and 14-3-3
binding (rather than motif phosphorylation) is demon- thus less sensitive to 14-3-3.
strated to suppress -COP binding. The findings show
14-3-3 to be a generic mediator of release from ER Iip35 Invariant Chains
retention, expand recognized binding motifs for 14-3-3, Invariant chains play a critical role in trafficking of newly
and suggest a mechanism for regulating forward traf- synthesized class II complexes to antigen-processing
ficking of homomeric and heteromeric protein com- compartments. Iip35 is retained in ER by a dibasic motif
plexes. (Schutze et al., 1994) and enjoys anterograde transport
in a phosphorylation (Anderson et al., 1999) and 14-
3-3-dependent fashion (Kuwana et al., 1998). KuwanaTrafficking to the Plasma Membrane
and coworkers (1998) suggested that regulation of 14-KCNK channels show widespread tissue expression
3-3 binding (via phosphorylation) could thus serve tofrom at least 17 separate genes (Lesage and Lazdunski,
control immune signal transduction. These observations2000; Goldstein et al., 2001). Subject to regulation in
can be rationalized by mutually exclusive binding ofmagnitude and character by a panoply of natural and
-COP and 14-3-3 as observed here: Iip35 bindsmedicinal agents, the channels are notable in both struc-
-COP and is retained in ER when the N terminus bearsture and function because they carry two pore-forming
no phosphate (MHRRRSRSC-), while phosphorylationP loops on each subunit (K2P channels) and form back-
of the adjacent release site (MHRRRSRSPC-) leads to 14-ground potassium channels (Ketchum et al., 1995;
3-3 binding, suppression of -COP association, and for-Goldstein et al., 1996; Bockenhauer et al., 2001; Ilan and
ward transport.Goldstein, 2001; Zilberberg et al., 2001). Background
channels regulate the function of nerves and muscles
A New Role and a Wealth of Nonclassical Sitesbecause increasing potassium leak stabilizes cells at
for 14-3-3negative resting potentials, thereby diminishing excit-
This study supports the conclusion that release fromability. Slow changes in KCNK3 current magnitude have
ER retention should be added to the long list of functionsbeen implicated in cardiac and nervous tissue re-
attributed to 14-3-3 variants. Previously implicated insponses to hormones, neurotransmitters, and drugs—
trafficking by studies of endocytosis-deficient yeastsome of which operate through cAMP-mediated path-
cells (Gelperin et al., 1995) and neuronal acetylcholineways (Kim et al., 1999; Kindler et al., 1999; Patel et al.,
receptors (Jeanclos et al., 2001), it was Kuwana and1999; Czirjak et al., 2000; Lopes et al., 2000; Talley et
colleagues (Kuwana et al., 1998) who explicitly sug-al., 2000). As the 14-3-3 release site in KCNK3 is a
gested that 14-3-3 might serve to regulate forward trans-canonical cAMP-dependent protein kinase A (PKA)
port of Iip35. How broadly operative this pathway isphosphorylation site, regulated expression of KCNK3
remains to be assessed. Just as COPI-mediated reten-channels may be a pathway for altering leak current
tion/retrieval motifs are widespread and variable in se-magnitude in response to external stimuli. Indeed, activ-
quence, so too, the four nonclassical 14-3-3 bindingity of potassium channels already in the membrane can
sites identified here are diverse enough to suggest thatalso be altered by 14-3-3 in a PKA-dependent fashion
many serine kinase phosphorylation sites will prove ca-in the case of a human cardiac channel (Kagan et al.,
pable of 14-3-3 binding (KCNK3, -RRSSV; KCNK9,2002) and in a calcium/calmodulin kinase II-dependent
-RRKSV; 4, -RSLSV-; and Iip35, -RSRSC-). Further, itmanner (via a third protein) in Drosophila neuromuscular
is possible that some classical sites mediate release,junctions (Schopperle et al., 1998; Zhou et al., 1999).
as altering the KCNK3 C terminus to a classical motifNicotinic receptors are neurotransmitter-gated ion
yielded both 14-3-3 binding and surface expression (Fig-channels implicated in memory, nociception, addiction,
ure 2). It is also unknown whether 14-3-3-mediated re-epilepsy, and Parkinson’s disease (Lindstrom, 1997).
lease from ER is limited to dibasic sites on membraneThe receptors assemble from 11 subunit isoforms, 2–9
proteins, can operate with other retention motifs suchand 2–4 (Drisdel, 2000), emerging on the surface as
as KDEL (Pelham, 1990), or employs additional proteins subunit homopentamers or  heteropentamers
to proceed.(McGehee, 1999). Keller and colleagues (Keller et al.,
2001) showed that a dibasic motif in the large cyto-
plasmic loop of skeletal muscle  subunits mediates ER Mutually Exclusive Binding and Release
from ER Retentionretention, while Jeanclos and coworkers (Jeanclos et
al., 2001) implicated a 14-3-3 protein (native isoform Regulated release of correctly assembled mixed com-
plexes from ER via masking of retention signals is aundetermined) in forward transport of nicotinic recep-
tors, demonstrating that activation of PKA by forskolin recognized strategy to control the type and quality of
membrane proteins that reach the surface (Klausner,enhanced binding of recombinant 14-3-3
 to the 4 loop
sequence -RSLSPVQ- and increased surface expression 1990; Zerangue et al., 1999; Standley et al., 2000; Zarei
et al., 2001). Here, we demonstrate that 14-3-3 can serveof 4 channels over 5-fold and 42 receptors 20%;
others observed a 2-fold increase in 42 receptor sur- as a general mediator for forward transport through inhi-
bition of COPI protein binding, allowing release fromface expression under similar conditions (Gopalakrish-
nan, 1997). The findings here that an 4 cytoplasmic ER retention. Evidence for mutually exclusive binding is
given in one case where retention and release sites areloop binds -COP and shows phosphorylation-depen-
dent interaction with 14-3-3 supports the notion that separate in the primary sequence (KCNK3) and another
where they are adjacent (Iip35). While steric interferenceescape of4 homomers from ER results from 14-3-3 bind-
Cell
586
by Western blotting and MALDI-MS (Keck Center). Extracts of ratcan rationalize binding of either -COP or 14-3-3 on
heart and skeletal muscle were prepared similarly. Binding assaysadjacent Iip35 sites, it is not known if the regulators
with recombinant 14-3-3 proteins were supplemented with 1% bo-interact directly when the sites are separated. Further
vine serum albumin.
support for the operation of this pathway in vivo are the
presence of 14-3-3 and PKA in ER and golgi (Nigam, Immunoprecipitation Protocols
1989; Kuwana et al., 1998), the effects of kinase activa- Proteins were extracted from rat brains by homogenization and
incubation on ice for 1 hr in cold Buffer B (50 mM Tris [pH 8.0], 1tors on 14-3-3 binding and forward transport of 4 and
mM EDTA, 150 mM NaCl, 1% NP-40) plus 0.5% deoxycholate and42 receptors (Gopalakrishnan, 1997; Jeanclos et al.,
0.1% SDS followed by centrifugation at 13,000  g for 30 min at2001), and cis-acting mutations that leave dibasic sig-
4C. The resulting supernatant (7 mg/ml total protein) was clarifiednals intact yet act on the separate site to produce for-
by centrifugation at 50,000  g for 30 min and dialyzed for 12 hr
ward transport of Emp47p (Schroder-Kohne, 1998). Evi- against Buffer B with 1% Triton X-100 at 4C. Triton X-100 was
dence that 14-3-3 augments forward transport not only added to 1% before extracts were incubated with 5 g of 14-3-3
monoclonal antibody or control mouse IgG (Sigma) overnight at 4C.of homomeric KCNK3 channels and 4 receptors but
Immune complexes were isolated with 50 l of Protein G Sepharoseheteromeric complexes (such as 42 receptors and
(Amersham Pharmacia Biotech, San Francisco, CA), washed withclass II-invariant chain complexes) where intersubunit
Buffer B with 1% Triton X-100, and eluted with SDS-PAGE sampleretention motif masking has been suspected to be suffi-
buffer. SDS-PAGE (12%) and Western blotting were performed by
cient suggests 14-3-3 may serve a role in normal release standard methods using ECL (Pierce, Rockford, IL). For protein ex-
from ER in both cases. As many proteins carry both pression analysis in oocytes, cells were homogenized, subjected to
SDS-PAGE, and visualized by Western blot analysis.ER retention and 14-3-3 binding motifs, the mechanism
Two-step affinity purification of HA-tagged KCNK3 or FLAG-described may operate broadly.
tagged Iip35 from COS-7 cells was performed 24 hr after transfection
using Lipofectamine (Invitrogen, Carlsbad, CA) by incubation for 1Experimental Procedures
hr in Buffer C (50 mM Tris [pH 8.5], 100 mM NaCl) with 1% Triton
X-100 and 0.1% SDS (HA) or 1% CHAPS (FLAG) and centrifugationYeast Two-Hybrid Identification of 14-3-3
at 13,000  g for 20 min at 4C. Extracts (2.5 mg total protein) wereThe Invitrogen ProQuest system, a human heart library, and the
incubated with 5 g HA or FLAG monoclonal antibody or controlpDBLeu vector encoding the last 16 residues in human KCNK3 as
mouse IgG overnight at 4C. Immune complexes were isolated withbait were employed. One million clones were screened and the
50 l of Protein G Sepharose, washed with Buffer C plus 1% Tritoninserts in three resultant clones were isolated, sequenced, and iden-
X-100 (HA) or 1% CHAPS (FLAG), and eluted from the beads withtified as described in Results.
50 M HA or FLAG peptide. Second-round immunoprecipitations
(IP2) were performed on 0.1 mg of recovered protein by incubationMutagenesis
with antibodies to -COP or 14-3-3, isolation via Protein G, andhKCNK3 was cloned from a human brain cDNA library (Clontech,
elution with SDS-PAGE sample buffer. One-fiftieth of the unfraction-Palo Alto, CA) with the primers 5-CGATGAAGCGGAGAACGTGCG
ated extract (50 g) was loaded in the control lysate lane of eachCAC-3 and 5-GGGCAGAAGGCAGCAGGGGCAGTC-3 and sub-
gel. To provide a conservative estimate for the minimal detectablecloned into pRAT (Bockenhauer et al., 2001). Mutations were made
level of 14-3-3 or -COP protein associated with KCNK3 in IP1 (andwith an XL Quickchange kit (Stratagene, La Jolla, CA) and confirmed
thereby assess the relative depletion of each in IP2), the amount ofby DNA sequencing. FLAG tags (DYKDDDDK) were inserted before
KCNK3 in an IP2 was normalized to its level in IP1 by serial dilutionthe start methionine; HA tags (YPYDVPDYA) were inserted at posi-
using Western blot analysis. The degree of further IP1 dilution thattion 213 in KCNK3.
still allowed for specific visualization was more than 1/20 for 14-
3-3 and 1/10 for -COP; this indicated that 5% and 10% of controlAntibodies
levels of 14-3-3 and -COP were readily observed and depletionPurchased polyclonal (p) and monoclonal (m) antibodies used in-
was greater than 95% and 90%, respectively.cluded: KCNK3 (p, APC024, Alomone Labs, Jerusalem, Israel); 14-
3-3 (m, SC1657, Santa Cruz Biotechnology, Santa Cruz, CA);
Production of Recombinant 14-3-3-COP (m, PC175, Calbiochem, LaJolla, CA); -COP (p, PA1601,
The gene encoding human 14-3-3 (P31946) was cloned via theAffinity Bioreagent, Golden, CO); Phosphoserine (p, AB1603, Chemi-
two-hybrid screening of the human heart library and subcloned intocon International, Temecula, CA); FLAG (m, F3165, Sigma-Aldrich,
pGEX 6P-1; 14-3-3 was released from the glutathione S-trans-St. Louis, MO); HA tag (m, 1583816; m, 1867423 and p, 1867423,
ferase (GST) fusion protein with PreScissionTM Protease (AmershamRoche Molecular Biochemicals, Indianapolis, IN); Transferrin recep-
Pharamcis Biotech).tor (p, SC9099, Santa Cruz, Santa Cruz, CA); Protein disulfide iso-
merase (PDI) (p, SPA890, StressGen Biotech., Victoria, Canada); and
ImmunofluorescenceIip35 (m, BYA91341, Accurate Chemicals, Westbury, NY).
COS-7 cells were seeded on poly-L-lysine-coated coverslips, trans-
fected with HA or Flag-tagged KCNK3 using calcium phosphate,Peptide Binding Studies
and 48 hr later were fixed in 4% paraformaldehyde for 30 min atPeptides and phosphopeptides were synthesized by the W.M. Keck
4C. For surface staining, cells were blocked with 20 mM sodiumBiotechnology Resource Center (New Haven, CT) with the excep-
phosphate (pH 7.4), 10% goat serum, 400 mM NaCl for 1 hr at 4C,tions of HA (I2149) and FLAG (F3290), which were purchased from
incubated with a rat monoclonal anti-HA antibody for 1 hr, washed,Sigma. A cysteine residue was added to the terminus of each peptide
and stained with Oregon Green-conjugated anti-rat antibody (Mo-that was linked to Sulfolink Coupling Gel (Pierce, Rockford, IL),
lecular Probes). Cells were permeabilized by including Triton X-100according to manufacturer’s instructions. Rat brain extract was pre-
(0.3%) in the blocking step, followed by incubation with a mousepared by homogenizing two frozen rat brains in 20 ml of cold Buffer
monoclonal anti-FLAG antibody and visualized with Oregon Green-A (10 mM HEPES [pH 7.4], 150 mM NaCl, protease inhibitor cocktail
conjugated goat anti-mouse antibody. Plasma membrane or ERtablets [PI; Roche Molecular Biochemicals Indianapolis, IN]) and
staining was confirmed by double labeling with polyclonal antibod-centrifuged at 800  g for 10 min at 4C. The resulting supernatant
ies to transferrin receptor or PDI, respectively, and Texas-red conju-was solubilized with 1% Triton X-100 for 1 hr and centrifuged for 1
gated goat-anti-rabbit antibodies.hr at 100,000  g at 4C. The final supernatant was then passed
over the various peptides immobilized on Sulfolink Gel (2 mg protein/
ml of coupled gel). The gel was washed with 6 bed volumes of Electrophysiology
Ooctyes were isolated from Xenopus laevis frogs (Nasco, Atkinson,phosphate buffered saline (PBS) with 1% Triton X-100 and bound
proteins were eluted with SDS-PAGE sample buffer and analyzed WI) treated with collagenase to ease removal of the follicular layer
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and injected with 0.1–1 ng of KCNK3 cRNA in 46 nl of sterile water. gieri, R. (1994). Binding of 14-3-3 proteins to the protein kinase Raf
and effects on its activation. Science 265, 1713–1716.Currents were measured 48 hr after injection by two-electrode volt-
age clamp (Warner Instruments Corp., Hamden, CT). Data were Fu, H., Subramanian, R.R., and Masters, S.C. (2000). 14-3-3 proteins:
filtered at 1 kHz and sampled at 4 kHz. Electrodes of 1.5 mm borosili- structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol.
cate glass tubes (Garner Glass Co., Claremount, CA) contained 3 40, 617–647.
M KCl and had resistances of 0.3 to 1 mOhm. Recordings were
Gaynor, E.C., and Emr, S.D. (1997). COPI-independent anterogradeperformed at room temperature with perfusion of 0.4–1 ml/min ND96
transport: cargo-selective ER to Golgi protein transport in yeast(in mM) 93 NaCl, 5 KCl, 1 MgCl2, 0.3 CaCl2, 5 HEPES. pH was adjusted COPI mutants. J. Cell Biol. 136, 789–802.to 7.5 or 6.5 where appropriate with NaOH or HCl. Potassium in the
Gelperin, D., Weigle, J., Nelson, K., Roseboom, P., Irie, K., Matsu-bath was altered by isotonic substitution of KCl for NaCl. Holding
moto, K., and Lemmon, S. (1995). 14-3-3 proteins: potential roles inpotential in all cases was 80 mV. Currents were evoked by step
vesicular transport and Ras signaling in Saccharomyces cerevisiae.depolarization from 135mV to 60mV in 15mV increments. Acid
Proc. Natl. Acad. Sci. USA 92, 11539–11543.sensitivity was determined by exchanging external bath solutions
during repeated step depolarization from holding potential to Goldstein, S.A.N., Price, L.A., Rosenthal, D.N., and Pausch, M.H.
30mV at 10 s intervals. (1996). ORK1, a potassium-selective leak channel with two pore
domains cloned from Drosophila melanogaster by expression in
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 93, 13256–Surface Binding Assay for KCNK3
13261.Xenopus oocytes were prepared and injected as described for elec-
trophysiology. The assay was as described by Zerangue and co- Goldstein, S.A.N., Bockenhauer, D., O’Kelly, I., and Zilberberg, N.
workers (Zerangue et al., 1999). Briefly, oocytes were blocked for (2001). Potassium leak channels and the KCNK family of two-
30 min in ND96 with 1% bovine serum albumin (BSA) at 4C, treated P-domain subunits. Nat. Rev. Neurosci. 2, 175–184.
with 5 g/ml mouse monoclonal anti-HA antibody in 1% BSA for 60 Gopalakrishnan, M. (1997). Regulation of human alpha4beta2 neu-
min at 4C, washed, and incubated with HRP-conjugated secondary ronal nicotinic acetylcholine receptors by cholinergic channel li-
antibody (goat anti-mouse IgG) in 1% BSA for 60 min at 4C. Cells gands and second messenger pathways. Mol. Pharmacol. 52,
were washed (1% BSA, 4C, 60 min) and transferred to ND96 without 524–534.
BSA. Individual oocytes were placed in 50 ml SuperSignal ELISA
Ilan, N., and Goldstein, S.A.N. (2001). KCNK0: single, cloned potas-Femto Maximum Sensitivity substrate (Pierce, Rockford, IL) at 22C
sium leak channels are multi-ion pores. Biophys. J. 80, 241–254.for 1 min. Chemiluminescence was quantified with a MultiSkan
Jeanclos, E.M., Lin, L., Treuil, M.W., Rao, J., DeCoster, M.A., andELISA plate reader.
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